Pharmacy Benefit News,Information and Expert Analysis Keyword Search Benefit Design & Cost ManagementAdherenceChronic CareClinical ServicesFormularyPerformance ManagementDrug Trend ReportDTR 2019DTR 2021DTR 2022News & UpdatesCEO InsightsIndustry newsIndustry predictionsIndustry updatesLegislationNavitus in the newsNavitus updatesPartnership AnnouncementPress ReleasePublic HealthRegulatoryPBM 101Choosing a PBMDrug manufacturingHybrid modelNon-traditional pbmPass-through modelPBM ModelsTraditional pbmWebinarsPeople & CultureAnniversaryARG: Green TeamAssociate spotlightCEO InsightsDEIExecutive spotlightResourcesEmployer GroupHealth PlanMemberPharmacyPlan SponsorResearchResidentServices & SolutionsAdherenceFW&AMTMNavitus KeyRDURRISESTARSpecialtyBiosimilarsChronic CareFormularySpecialty Drug SpendSpecialty SpendSuccess StoriesCase StudiesClient experienceClinical excellenceMember experienceTrend Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars Read More PBM 101: Why the Model Matters Read More Associate Resource Group Spotlight: Green Team Read More PBM 101: The Three PBM Business Models Read More An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM) Read More Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings Read More Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025 Read More Achieving Outstanding Results with Tailored Network Strategies Read More Breaking Through Barriers with Value-Based Plan Design Read More Finding a Solution to Lower Prescription Drug Costs Read More Empowered by Strategic Opportunities and Service Excellence Read More QALYiQ Program Delivers Significant Savings for Both Members and Health Plans Read More Page 1 of 2312345...Last »
